EU agency opens investigation into HPV vaccine after shot damages thousands of families

(NaturalNews) The European Medicines Agency (EMA) has launched a probe into the highly controversial HPV vaccination program following thousands of reports of young girls falling seriously ill after getting jabbed. Per the Swedish news source Svenska Dagbladet (SvD), the European Union’s version of the Food And Drug Administration (FDA) launched the investigation to determine whether or not the safety claims associated with Gardasil and Cervarix, the two HPV vaccines currently in circulation, are actually legitimate.

The multinational drug corporations behind the two vaccines, Merck & Co. and GlaxoSmithKline (GSK), respectively, say the vaccines are perfectly safe and come with minimal risk of side effects. But the many thousands of young girls throughout the world who’ve suffered serious side effects, including several hundred recently featured in a Danish documentary that aired on Denmark’s TV2 network, claim otherwise, reporting major health failures almost immediately following the jab.

HPV vaccines have already been administered to some 70 million women worldwide, but their safety and effectiveness is questionable at best. The science used to justify their commercial approval simply doesn’t stand up to scrutiny, and yet many countries throughout the world have adopted HPV vaccines as a preventative medicine for preventing cervical cancer.

Canadian researchers published a study in 2013 revealing that the industry-sponsored trials used to justify commercial approval of HPV vaccines are “largely inadequate” and present “evidence of selective reporting of results from clinical trials,” meaning vaccine companies cherry-pick data to suit their own agenda.

“[T]he widespread optimism regarding HPV vaccines long-term benefits appears to rest on a number of unproven assumptions (or such which are at odd with factual evidence) and significant misinterpretation of available data,” the team wrote.